Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Shc and insulin receptor substrate 1 (IRS-1) are cytoplasmic substrates of tyrosine kinase receptors that engage, localize, and activate downstream SH2 enzymes. Each contains a phosphotyrosine-binding (PTB) domain that is structurally unrelated to SH2 domains. We have designed high-affinity, cellula...
Tallennettuna:
| Julkaisussa: | Mol Cell Biol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
1997
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC231843/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9032245/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.17.3.1180 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
